Clinical Trials for Eureka Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Eureka Therapeutics

Clinical Trials (4)

Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma

EARLY_PHASE1Not yet recruiting

Started: Dec 31, 2025 · Completed: Dec 31, 2028

3 conditions2 sponsors1 location

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

PHASE1/PHASE2Recruiting

21 participants

Started: Jun 1, 2024 · Completed: Dec 31, 2027

15 conditions2 sponsors2 locations

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

PHASE1/PHASE2Recruiting

15 participants

Started: Jul 19, 2022 · Completed: Jan 31, 2028

6 conditions1 sponsor2 locations

T-Cell Therapy (ECT204) in Adults With Advanced HCC

PHASE2Recruiting

20 participants

Started: Mar 11, 2022 · Completed: Dec 31, 2027

4 conditions1 sponsor5 locations